# Absolute Bioavailability Study of Cizutamig in Healthy Adult Participants

> **NCT07236411** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Candid Therapeutics** · enrollment: 24 (estimated)

## Conditions studied

- Healthy Participants Study

## Interventions

- **BIOLOGICAL:** cizutamig
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT07236411
- **Lead sponsor:** Candid Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-12-04
- **Primary completion:** 2026-06
- **Final completion:** 2026-06
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2026-05-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07236411

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07236411, "Absolute Bioavailability Study of Cizutamig in Healthy Adult Participants". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07236411. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*